Targeting castration-resistant prostate cancer with a novel ROR

Jianwei ZHENG; Junfeng WANG; Qian WANG; Hongye ZOU; Hong WANG; Zhenhua ZHANG; Jianghe CHEN; Qianqian WANG; Panxia WANG; Yueshan ZHAO; Jing LU; Xiaolei ZHANG; Songtao XIANG; Haibin WANG; Jinping LEI; Hong-Wu CHEN; Peiqing LIU; Yonghong LIU; Fanghai HAN; Junjian WANG.
Acta Pharmaceutica Sinica B ; (6): 2313-2322, 2020.
Artículo en Inglés | WPRIM | ID: wpr-881113

Documentos relacionados

  1. Targeting castration-resistant prostate cancer with a novel ROR<i>γ</i> antagonist elaiophylin.
  2. Diagnosis and management of neuroendocrine prostate cancer.
  3. Biomedical research in france and brazil: an analysis of significant differences and ethical issues
  4. Photothermal therapy: a novel potential treatment for prostate cancer.
  5. Targeting Prostate Cancer, the 'Tousled Way'.
  6. [Adionuclide therapy for metastatic castration-resistant prostate cancer: New advances].
  7. [Metastatic castration-resistant prostate cancer].
  8. Emerging systemic treatment for metastatic castration-resistant prostate cancer: a review of recent randomized controlled trials.
  9. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.
  10. Genetic Testing in Prostate Cancer.